03/28/2025
7:35 AM | CHIMERIX INC (Subject)
Jazz Pharmaceuticals (Filed by)
| Form SC TO-T/A | |
03/21/2025
5:54 AM | CHIMERIX INC (Subject)
Jazz Pharmaceuticals (Filed by)
| Form SC TO-T | |
03/12/2025
1:24 PM | Iannone Robert (Reporting)
Jazz Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2025
5:17 PM | Carr Patricia (Reporting)
Jazz Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2025
5:19 PM | Henderson Mary Elizabeth (Reporting)
Jazz Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/10/2025
5:01 PM | Iannone Robert (Reporting)
Jazz Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/10/2025
4:36 PM | Carr Patricia (Reporting)
Jazz Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/07/2025
5:57 PM | Jazz Pharmaceuticals (Issuer)
Patil Neena M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2025
6:00 PM | Jazz Pharmaceuticals (Issuer)
Pearce Samantha (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2025
5:43 PM | COZADD BRUCE C (Reporting)
Jazz Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2025
5:45 PM | GALA RENEE D (Reporting)
Jazz Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for JAZZ and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Jazz Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. |
03/07/2025
5:49 PM | Iannone Robert (Reporting)
Jazz Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2025
5:51 PM | Jazz Pharmaceuticals (Issuer)
Johnson Philip L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2025
4:14 PM | Iannone Robert (Reporting)
Jazz Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/07/2025
4:04 PM | Iannone Robert (Reporting)
Jazz Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/07/2025
2:15 PM | Henderson Mary Elizabeth (Reporting)
Jazz Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/06/2025
3:42 PM | CHIMERIX INC (Subject)
Jazz Pharmaceuticals (Filed by)
| Form SC TO-C | |
03/05/2025
3:50 PM | CHIMERIX INC (Subject)
Jazz Pharmaceuticals (Filed by)
| Form SC TO-C | |
03/05/2025
6:09 AM | Jazz Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/05/2025
6:11 AM | Jazz Pharmaceuticals (Subject)
| Form SC TO-C | |
03/03/2025
7:19 PM | Henderson Mary Elizabeth (Reporting)
Jazz Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/03/2025
7:22 PM | Iannone Robert (Reporting)
Jazz Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/03/2025
6:35 PM | Jazz Pharmaceuticals (Issuer)
Pearce Samantha (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/03/2025
6:24 PM | Jazz Pharmaceuticals (Issuer)
Johnson Philip L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/03/2025
6:29 PM | GALA RENEE D (Reporting)
Jazz Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/03/2025
6:13 PM | COZADD BRUCE C (Reporting)
Jazz Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/03/2025
6:18 PM | Jazz Pharmaceuticals (Issuer)
Patil Neena M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/03/2025
6:21 PM | Carr Patricia (Reporting)
Jazz Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/03/2025
3:44 PM | COZADD BRUCE C (Reporting)
Jazz Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/28/2025
4:43 PM | Carr Patricia (Reporting)
Jazz Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/27/2025
7:05 PM | Carr Patricia (Reporting)
Jazz Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/27/2025
3:56 PM | Jazz Pharmaceuticals (Subject)
Patil Neena M (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/26/2025
6:34 AM | Jazz Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/05/2025
4:41 PM | COZADD BRUCE C (Reporting)
Jazz Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/22/2025
5:55 PM | COZADD BRUCE C (Reporting)
Jazz Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/22/2025
5:58 PM | Iannone Robert (Reporting)
Jazz Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/22/2025
5:43 PM | Jazz Pharmaceuticals (Issuer)
Patil Neena M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/22/2025
5:46 PM | Carr Patricia (Reporting)
Jazz Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/22/2025
5:50 PM | GALA RENEE D (Reporting)
Jazz Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/22/2025
5:40 PM | Jazz Pharmaceuticals (Issuer)
Pearce Samantha (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/13/2025
6:45 AM | Jazz Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Trump to unlock 15-figure fortune for America (May 3rd) ? (Ad) We were shown this map by former Presidential Advisor, Jim Rickards, one of the most politically connected men in America.
Rickards has spent his fifty-year career in the innermost circles of the U.S. government and banking.
And he believes Trump could soon release this frozen asset to the public.
 But something even more spectacular is bound to happen. And those who know what to expect could make |
01/06/2025
3:22 PM | COZADD BRUCE C (Reporting)
Jazz Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/16/2024
3:43 PM | Jazz Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/09/2024
5:45 PM | GALA RENEE D (Reporting)
Jazz Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/02/2024
5:05 PM | COZADD BRUCE C (Reporting)
Jazz Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/02/2024
3:20 PM | Carr Patricia (Reporting)
Jazz Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/26/2024
4:02 PM | Jazz Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/21/2024
5:06 AM | Jazz Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/13/2024
4:44 PM | Jazz Pharmaceuticals (Issuer)
Patil Neena M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/12/2024
10:44 AM | BlackRock, Inc. (Filed by)
Jazz Pharmaceuticals (Subject)
| Form SC 13G/A | |
11/08/2024
4:55 PM | Jazz Pharmaceuticals (Subject)
Patil Neena M (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/07/2024
6:32 AM | Jazz Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/06/2024
3:06 PM | Jazz Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/05/2024
4:00 PM | COZADD BRUCE C (Reporting)
Jazz Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/01/2024
2:19 PM | COZADD BRUCE C (Reporting)
Jazz Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/21/2024
3:11 PM | BlackRock, Inc. (Filed by)
Jazz Pharmaceuticals (Subject)
| Form SC 13G/A | |
10/16/2024
3:13 PM | Jazz Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/11/2024
10:38 AM | Henderson Mary Elizabeth (Reporting)
Jazz Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2024
6:50 PM | Henderson Mary Elizabeth (Reporting)
Jazz Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/28/2024
1:27 PM | Jazz Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/06/2024
5:39 PM | Cook Jennifer E. (Reporting)
Jazz Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/06/2024
5:39 PM | Jazz Pharmaceuticals (Issuer)
McSharry Heather Ann (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/06/2024
5:40 PM | Jazz Pharmaceuticals (Issuer)
O'Keefe Kenneth W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/06/2024
5:40 PM | Jazz Pharmaceuticals (Issuer)
ORiordan Anne (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/06/2024
5:41 PM | Jazz Pharmaceuticals (Issuer)
RIEDEL NORBERT G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/06/2024
5:42 PM | Jazz Pharmaceuticals (Issuer)
Smith Mark Douglas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/06/2024
5:42 PM | Jazz Pharmaceuticals (Issuer)
Winningham Rick E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/06/2024
5:45 PM | ENRIGHT PATRICK G (Reporting)
Jazz Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/06/2024
3:48 PM | Hamill Laura (Reporting)
Jazz Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/06/2024
3:50 PM | Jazz Pharmaceuticals (Issuer)
Kennedy Patrick (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/06/2024
3:52 PM | Jazz Pharmaceuticals (Issuer)
Mulligan Seamus (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/06/2024
3:53 PM | Jazz Pharmaceuticals (Issuer)
Pearce Samantha (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/05/2024
8:57 PM | Jazz Pharmaceuticals (Subject)
Winningham Rick E (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/05/2024
8:29 PM | Jazz Pharmaceuticals (Subject)
McSharry Heather Ann (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/05/2024
8:35 PM | Jazz Pharmaceuticals (Subject)
O'Keefe Kenneth W (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/05/2024
8:42 PM | Jazz Pharmaceuticals (Subject)
ORiordan Anne (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/05/2024
8:49 PM | Jazz Pharmaceuticals (Subject)
RIEDEL NORBERT G (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/05/2024
8:55 PM | Jazz Pharmaceuticals (Subject)
Smith Mark Douglas (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/05/2024
8:19 PM | Cook Jennifer E. (Reporting)
Jazz Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/01/2024
6:33 AM | Jazz Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/31/2024
3:06 PM | Jazz Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/30/2024
7:11 PM | Hamill Laura (Reporting)
Jazz Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
07/22/2024
3:46 PM | Jazz Pharmaceuticals (Filer)
| Form DEFA14A | |
07/22/2024
6:57 AM | Jazz Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/11/2024
7:15 PM | Carr Patricia (Reporting)
Jazz Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
3:44 PM | Carr Patricia (Reporting)
Jazz Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/07/2024
4:31 PM | Jazz Pharmaceuticals (Issuer)
Patil Neena M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/02/2024
6:38 AM | Jazz Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/09/2024
3:39 PM | GALA RENEE D (Reporting)
Jazz Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
